Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry
- PMID: 26369829
- DOI: 10.1038/leu.2015.220
Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry
Comment in
-
Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: the authors' reply.Leukemia. 2016 Mar;30(3):740-1. doi: 10.1038/leu.2015.339. Epub 2016 Jan 12. Leukemia. 2016. PMID: 26754826 No abstract available.
-
Effectiveness of azacitidine in higher-risk myelodysplastic syndromes.Leukemia. 2016 Aug;30(8):1795-6. doi: 10.1038/leu.2016.117. Epub 2016 May 20. Leukemia. 2016. PMID: 27198054 No abstract available.
Comment on
-
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry.Leukemia. 2015 Sep;29(9):1875-81. doi: 10.1038/leu.2015.115. Epub 2015 May 6. Leukemia. 2015. PMID: 25943181
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
